rs397516955
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004415.4(DSP):c.699G>A(p.Trp233Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
DSP
NM_004415.4 stop_gained
NM_004415.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-7562753-G-A is Pathogenic according to our data. Variant chr6-7562753-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 44946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-7562753-G-A is described in Lovd as [Pathogenic]. Variant chr6-7562753-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | NP_001305963.1 | ||
DSP | NM_001008844.3 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | NP_001008844.1 | ||
DSP | NM_001406591.1 | c.699G>A | p.Trp233Ter | stop_gained | 5/11 | NP_001393520.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | 1 | ENSP00000396591 | A2 | ||
DSP | ENST00000710359.1 | c.699G>A | p.Trp233Ter | stop_gained | 5/24 | ENSP00000518230 | A2 | |||
DSP | ENST00000506617.1 | n.217G>A | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change creates a premature translational stop signal (p.Trp233*) in the DSP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (PMID: 16917092, 24503780; Invitae). ClinVar contains an entry for this variant (Variation ID: 44946). For these reasons, this variant has been classified as Pathogenic. - |
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 15, 2019 | proposed classification - variant undergoing re-assessment, contact laboratory - |
Cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | Nov 28, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies indicate this variant results in nonsense-mediated decay (Yang et al., 2006); Not observed in large population cohorts (gnomAD); Reported in ClinVar as pathogenic or likely pathogenic (ClinVar Variant ID# 44946; ClinVar); This variant is associated with the following publications: (PMID: 16917092, 27532257, 17363426, 20738328, 31402444, Atak2021[Computational], 34076677, 32372669, 34352074, 33684294, 28471438, 35325485, 36142674, 24503780) - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The p.W233* pathogenic mutation (also known as c.699G>A), located in coding exon 5 of the DSP gene, results from a G to A substitution at nucleotide position 699. This changes the amino acid from a tryptophan to a stop codon within coding exon 5. This alteration has been reported in dilated cardiomyopathy (DCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC) cohorts (Yang Z et al. Circ Res, 2006 Sep;99:646-55; Haggerty CM et al. Genet Med, 2017 11;19:1245-1252; Walsh R et al. Genet Med, 2017 02;19:192-203). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 21, 2020 | Variant summary: DSP c.699G>A (p.Trp233X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. In addition, in vitro studies of the affected patients blood cells support that this nonsense substitution results in haploinsufficiency, probably due to increased decay of nonsense mRNA (Yang_2006). Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251830 control chromosomes (gnomAD). c.699G>A has been reported in individuals affected with arrhythmogenic right ventricular cardiomyopathy (Yang_2006, ClinVar submitter) as well as one individual affected with dilated cardiomyopathy who was Caucasian adult and segregated with disease in at least on relative (Pugh_2014, ClinVar database SCV000061748.4). At least one in vitro study showed that this mutant results in DSP protein formed perinuclear aggregates and was neither localized at the cell membrane nor seen diffusively in the cytoplasm (Yang_2006). Five ClinVar submitters (evaluation after 2014) cite the variant as pathogenic (3x) and likely pathogenic (2x). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Woolly hair-skin fragility syndrome;C1843896:Arrhythmogenic right ventricular dysplasia 8;C1852127:Keratosis palmoplantaris striata 2;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma;C1864826:Lethal acantholytic epidermolysis bullosa;C4014393:Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at